UnitedHealth Group stock continues to trade near $293 — down roughly 50% from its 52-week high near $600 — as the nation's largest health insurer grapples with a convergence of crises that have erased more than $250 billion in market capitalization. The latest blow: CMS proposed a 0.09% Medicare Advantage rate increase for 2027, effectively a funding freeze that falls catastrophically short of the 4-6% increase insurers had expected. The announcement triggered an immediate sell-off across the managed care sector, with UNH leading the decline. The company reported $447.6 billion in full-year 2025 revenue — up 12% year-over-year — but profits fell to $12.1 billion from $14.4 billion, the lowest since 2018.

The Medicare Advantage rate shock compounds an already bruising period for UnitedHealth. The DOJ is conducting a criminal investigation into Medicare billing practices, focused on diagnoses that inflated federal payments. The probe has expanded to include Optum Rx and physician reimbursement practices at company-employed medical groups. A Senate Judiciary Committee review of 50,000 internal documents found that UnitedHealth captured more diagnosis codes than any other MA insurer, raising questions about systematic upcoding. Meanwhile, the company has announced plans to reduce Medicare Advantage membership by 1.3-1.4 million in 2026, a deliberate retreat from unprofitable markets that will further pressure revenue growth.

The implications ripple across the entire healthcare ecosystem. UnitedHealth's Optum division is the largest employer of physicians in the United States, and its reimbursement practices directly affect thousands of dental and medical practices that accept UnitedHealthcare plans. A sustained MA rate freeze would force UNH to tighten provider reimbursements, narrow networks, and reduce benefits — hitting practices that depend on MA patient volume. For dental practices, UnitedHealthcare Dental is one of the largest commercial payers; any financial pressure on the parent company could eventually flow through to dental reimbursement negotiations.

Watch for the final 2027 MA rate announcement expected in April — CMS sometimes adjusts upward from the initial proposal, though the 0.09% starting point leaves little room for a meaningful increase. The DOJ probe timeline is unpredictable but could produce enforcement actions that create additional stock pressure. Also monitor UNH's Q1 2026 earnings for early signals on how the planned 1.3-1.4 million membership reduction is affecting revenue, and whether Optum Health can stabilize after posting its first operating losses in recent memory. At $261 billion in market cap, UNH remains a giant — but it is a giant under siege from regulators, rate-setters, and its own operational complexity.